

Fundamental dimension Equity attribute | DBOEYPeer $35.02▼-1.10% Cap $63.16BP/E 27.0x QuantScore39/100 | BOLSYLeader $14.30▲+4.87% Cap $23.83BP/E 22.5x QuantScore61/100 | CBOEPeer $340.42▲+3.88% Cap $35.55BP/E 26.5x QuantScore59/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
85/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 43/100 | 68/100 | 52/100 |
Health Piotroski, Altman Z, leverage & liquidity | 26/100 | 50/100 | 77/100 |
Growth Revenue / earnings growth & margins | 36/100 | 43/100 | 44/100 |
Sentiment Analyst ratings, targets & revisions | 6/100 | — | 50/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 27.0x | 22.5x | 26.5x |
Forward P/E (next FY) | 24.1x | 3.8x | 24.2x |
EV / EBITDA (TTM) | 24.6x | 13.4x | 17.0x |
Price / Sales | 7.3x | 11.0x | 7.0x |
Price / Free Cash Flow | — | 51.0x | 1601.4x |
PEG ratio | 3.56 | 1.35 | 0.53 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 7 / 9 | 5 / 9 |
Altman Z-Score | 0.17 (Distress) | 3.13 (Safe) | 6.14 (Safe) |
Total debt / equity | 3.26 | 0.80 | 0.28 |
Quick ratio | 1.1x | 1.9x | 1.6x |
Interest coverage | 20.1x | 2.8x | 33.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +1.4% | +6.8% | +15.1% |
Net income growth YoY | -1.7% | -1.8% | +43.8% |
Gross margin (TTM) | 72.9% | 79.2% | 52.3% |
Operating margin (FY) | 40.3% | 64.7% | 32.1% |
FCF margin (FY) | 37.2% | 1.6% | 24.5% |
5. Trailing price performancePrice change over period |
1M return | +8.9% | +37.6% | +27.2% |
3M return | +19.5% | +57.7% | +19.4% |
6M return | +12.0% | +26.1% | +12.1% |
Year to date | +33.2% | +80.8% | +35.6% |
1Y return | +32.0% | +106.9% | +42.6% |
3Y return | +113.7% | +105.5% | +109.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $34.88 -0.4% premium | $16.98 +18.8% upside | $245.21 -28.0% premium |
Wall Street consensus target | — — | — — | $339.00 -0.4% · range $300.00–$450.00 |
Consensus stance | 33% Buy67% Hold0% Sell | — | 48% Buy42% Hold10% Sell |